Skip to main content

Advertisement

SpringerLink
Log in

Age-related alteration in cerebral blood flow and energy failure is correlated with cognitive impairment in the senescence-accelerated prone mouse strain 8 (SAMP8)

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Cerebrovascular dysfunction is an early pathogenic event in Alzheimer’s disease (AD) and plays a key role in the disease process. Cerebral hypoperfusion, brain glucose hypometabolism and disrupted blood–brain barrier (BBB) integrity contributed to the onset and progression of AD. However, the relationships between the age-related cognitive impairment and cerebral blood flow (CBF), energy metabolism and BBB have not been clearly explained. In this study, we investigated the cognitive function, CBF, BBB damage and expression level of glucose transporter (GLUT) 1 and 3 of senescence-accelerated mouse prone 8 (SAMP8), and the correlations between each of them were analyzed. When compared with SAMR1 (senescence-accelerated mouse resistant 1), the cognitive abilities of SAMP8 were damaged apparently even at 4 months of age, showing up a slower and more capricious acquisition in Morris water maze tasks. In both SAMP8 and SAMR1, reduced CBF and increased BBB leakage were observed with increasing age, but an earlier and more severe impairment was detected in SAMP8. In addition, alterations of GLUT1 and GLUT3 protein expression in cortex and hippocampus were more prominent in SAMP8. Correlation analysis demonstrated that the increased escape latency was correlated negatively with CBF and expression of glucose transporters; and positively with BBB permeability in the hippocampus. These results suggested that CBF, BBB integrity, the expression of GLUT1 and GLUT3 were significantly affected by age and strain, which were also closely associated with cognitive ability. The alteration in CBF and energy failure induced by aging and vascular insults resulted in cognitive decline in SAMP8.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Scheibel AB, Duong TH, Jacobs R (1989) Alzheimer’s disease as a capillary dementia. Ann Med 21:103–107

    Article  PubMed  CAS  Google Scholar 

  2. de la Torre JC (2004) Is Alzheimer’s disease a neurodegenerative or a vascular disorder? data, dogma, and dialectics. Lancet Neurol 3:184–190

    Article  PubMed  Google Scholar 

  3. Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ, Gorno-Tempini ML, Schuff N (2005) Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 234:851–859

    Article  PubMed  Google Scholar 

  4. Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, Breteler MM (2005) Cerebral hypoperfusion and clinical onset of dementia: the rotterdam study. Ann Neurol 57(6):789–794

    Article  PubMed  Google Scholar 

  5. Hirao K, Ohnishi T, Hirata Y, Yamashita F, Mori T, Moriguchi Y, Matsuda H, Nemoto K, Imabayashi E, Yamada M, Iwamoto T, Arima K, Asada T (2005) The prediction of rapid conversion to Alzheimer’s disease in mild cognitive impairment using regional cerebral blood flow SPECT. Neuroimage 28:1014–1021

    Article  PubMed  Google Scholar 

  6. Mosconi L, De Santi S, Li J, Tsui WH, Li Y, Boppana M, Laska E, Rusinek H, de Leon MJ (2008) Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol Aging 29(5):676–692

    Article  PubMed  CAS  Google Scholar 

  7. Mosconi L, Sorbi S, de Leon MJ, Li Y, Nacmias B, Myoung PS, Tsui W, Ginestroni A, Bessi V, Fayyazz M, Caffarra P, Pupi A (2006) Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer’s disease. J Nucl Med 47(11):1778–1786

    PubMed  CAS  Google Scholar 

  8. Blass JP (2002) Alzheimer’s disease and Alzheimer’s dementia: distinct but overlapping entities. Neurobiol Aging 23(6):1077–1084

    Article  PubMed  Google Scholar 

  9. Mosconi L, Tsui WH, De Santi S, Li J, Rusinek H, Convit A, Li Y, Boppana M, de Leon MJ (2005) Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology 64(11):1860–1867

    Article  PubMed  CAS  Google Scholar 

  10. Mosconi L, De Santi S, Brys M, Tsui WH, Pirraglia E, Glodzik-Sobanska L, Rich KE, Switalski R, Mehta PD, Pratico D, Zinkowski R, Blennow K, de Leon MJ (2008) Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints. Biol Psychiatry 63(6):609–618

    Article  PubMed  CAS  Google Scholar 

  11. Desgranges B, Baron JC, de la Sayette V, Petit-Taboué MC, Benali K, Landeau B, Lechevalier B, Eustache F (1998) The neural substrates of memory systems impairment in Alzheimer’s disease: a PET study of resting brain glucose utilization. Brain 121(Pt4):611–631

    Article  Google Scholar 

  12. Morley JE, Kumar VB, Bernardo AE, Farr SA, Uezu K, Tumosa N, Flood JF (2000) Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides 21(12):1761–1767

    Article  PubMed  CAS  Google Scholar 

  13. Pettersen JA, Sathiyamoorthy G, Gao FQ, Szilagyi G, Nadkarni NK, St George-Hyslop P, Rogaeva E, Black SE (2008) Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the sunnybrook dementia study. Arch Neurol 65:790–795

    Article  PubMed  Google Scholar 

  14. Heyman A, Fillenbaum GG, Welsh-Bohmer KA, Gearing M, Mirra SS, Mohs RC, Peterson BL, Pieper CF (1998) Cerebral infarcts in patients with autopsy-proven Alzheimer’s disease: CERAD, part XVIII. Consortium to establish a registry for Alzheimer’s disease. Neurology 51(1):159–162

    Article  PubMed  CAS  Google Scholar 

  15. Kalaria RN (2003) Vascular factors in Alzheimer’s disease. Int Psychogeriatr 15(Suppl 1):47–52

    Article  PubMed  Google Scholar 

  16. Bowman GL, Kaye JA, Moore M, Waichunas D, Carlson NE, Quinn JF (2007) Blood–brain barrier impairment in Alzheimer disease: stability and functional significance. Neurology 68(21):1809–1814

    Article  PubMed  CAS  Google Scholar 

  17. Del Valle J, Duran-Vilaregut J, Manich G, Camins A, Pallàs M, Vilaplana J, Pelegrí C (2009) Time-course of blood–brain barrier disruption in senescence-accelerated mouse prone 8 (SAMP8) mice. Int J Dev Neurosci 27(1):47–52

    Article  PubMed  Google Scholar 

  18. Pelegrí C, Canudas AM, del Valle J, Casadesus G, Smith MA, Camins A, Pallàs M, Vilaplana J (2007) Increased permeability of blood–brain barrier on the hippocampus of a murine model of senescence. Mech Ageing Dev 128(9):522–528

    Article  PubMed  Google Scholar 

  19. Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A (2003) Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer’s disease: a PET follow-up study. Eur J Nucl Med Mol Imaging 30:1104–1113

    Article  PubMed  Google Scholar 

  20. Friedland RP, Jagust WJ, Huesman RH, Koss E, Knittel B, Mathis CA, Ober BA, Mazoyer BM, Budinger TF (1989) Regional cerebral glucose transport and utilization in Alzheimer’s disease. Neurology 39(11):1427–1434

    Article  PubMed  CAS  Google Scholar 

  21. Jagust WJ, Seab JP, Huesman RH, Valk PE, Mathis CA, Reed BR, Coxson PG, Budinger TF (1991) Diminished glucose transport in Alzheimer’s disease: dynamic PET studies. J Cereb Blood Flow Metab 11(2):323–330

    Article  PubMed  CAS  Google Scholar 

  22. Hunt A, Schonknecht P, Henze M, Seidl U, Haberkorn U, Schroder J (2007) Reduced cerebral glucose metabolism in patients at risk for Alzheimer’s disease. Psychiatry Res 155:147–154

    Article  PubMed  CAS  Google Scholar 

  23. Piert M, Koeppe RA, Giordani B, Berent S, Kuhl DE (1996) Diminished glucose transport and phosphorylation in Alzheimer’s disease determined by dynamic FDG-PET. J Nucl Med 37(2):201–208

    PubMed  CAS  Google Scholar 

  24. Shim YS, Morris JC (2011) Biomarkers predicting Alzheimer’s disease in cognitively normal aging. J Clin Neurol 7(2):60–68

    Article  PubMed  Google Scholar 

  25. Mosconi L, Tsui WH, Rusinek H, De Santi S, Li Y, Wang GJ, Pupi A, Fowler J, de Leon MJ (2007) Quantitation, regional vulnerability and kinetic modeling of brain glucose metabolism in mild Alzheimer’s disease. Eur J Nucl Med Mol Imaging 34:1467–1479

    Article  PubMed  CAS  Google Scholar 

  26. Tanaka T, Wakamatsu T, Daijo H, Oda S, Kai S, Adachi T, Kizaka-Kondoh S, Fukuda K, Hirota K (2010) Persisting mild hypothermia suppresses hypoxia-inducible factor-1alpha protein synthesis and hypoxia-inducible factor-1-mediated gene expression. Am J Physiol Regul Integr Comp Physiol 298(3):R661–R671

    Article  PubMed  CAS  Google Scholar 

  27. Zovein A, Flowers-Ziegler J, Thamotharan S, Shin D, Sankar R, Nguyen K, Gambhir S, Devaskar SU (2004) Postnatal hypoxic-ischemic brain injury alters mechanisms mediating neuronal glucose transport. Am J Physiol Regul Integr Comp Physiol 286(2):R273–R282

    Article  PubMed  CAS  Google Scholar 

  28. O’Sullivan M (2008) Leukoaraiosis. Pract Neurol 8(1):26–38

    Article  PubMed  Google Scholar 

  29. Pietrini P, Furey ML, Alexander GE, Mentis MJ, Dani A, Guazzelli M, Rapoport SI, Schapiro MB (1999) Association between brain functional failure and dementia severity in Alzheimer’s disease: resting versus stimulation PET study. Am J Psychiatry 156(3):470–473

    PubMed  CAS  Google Scholar 

  30. de la Torre JC (2008) Pathophysiology of neuronal energy crisis in Alzheimer’s disease. Neurodegener Dis 5(3–4):126–132

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China

    Xuezhu Zhang, Guomin Li, Lin Guo, Kun Nie, Yujie Jia, Lan Zhao & Jianchun Yu

  2. First People’s Hospital of Chenzhou City, Chenzhou, 423000, Hunan Province, China

    Guomin Li

Authors
  1. Xuezhu Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guomin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lin Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kun Nie
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yujie Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lan Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jianchun Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jianchun Yu.

Additional information

Xuezhu Zhang and Guomin Li have equally contributed to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, X., Li, G., Guo, L. et al. Age-related alteration in cerebral blood flow and energy failure is correlated with cognitive impairment in the senescence-accelerated prone mouse strain 8 (SAMP8). Neurol Sci 34, 1917–1924 (2013). https://doi.org/10.1007/s10072-013-1407-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-013-1407-8

Keywords

Search

Navigation